In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Poster Session 3: Chronic Heart Failure - Clinical
Session

Congress : Heart Failure 2019

Topic : Other

  • Session type : Poster Session
  • Date : 27 May 2019
  • Time : 08:30 - 18:00

23 presentations in this session

Evaluation of the effectiveness of lisinicore and losartan in patients with chronic heart failure

Congress : Heart Failure 2019

  • Session : Chronic Heart Failure - Clinical
  • Speaker : U Kamilova (Tashkent,UZ)

Profile and follow up of the elderly patient with heart failure

Congress : Heart Failure 2019

  • Session : Chronic Heart Failure - Clinical
  • Speaker : D Enriquez Vazquez (Lugo,ES)

The impact of diabetes mellitus and microvascular complications on heart failure biomarkers

Congress : Heart Failure 2019

  • Session : Chronic Heart Failure - Clinical
  • Speaker : F Fringu (Cluj Napoca,RO)

Cardiopulmonary exercise testing for assessing frailty status in stable elderly patients with heart failure

Congress : Heart Failure 2019

  • Session : Chronic Heart Failure - Clinical
  • Speaker : A Hirashiki (Obu,JP)

Sleep disordered breathing in patients with heart failure: association with biomarkers and clinical parameters

Congress : Heart Failure 2019

  • Session : Chronic Heart Failure - Clinical
  • Speaker : EA Medvedeva (Saint-Petersburg,RU)

Evolution of death due to cancer in heart failure ambulatory patients during 17 years follow-up

Congress : Heart Failure 2019

  • Session : Chronic Heart Failure - Clinical
  • Speaker : A Bayes Genis (Badalona,ES)

Sleep apnea screening in heart failure: an exploratory analysis

Congress : Heart Failure 2019

  • Session : Chronic Heart Failure - Clinical
  • Speaker : R Ventura Gomes (Vila Franca De Xira,PT)

Diabetes is the strongest predictor of limited exercise capacity in patients with chronic heart failure

Congress : Heart Failure 2019

  • Session : Chronic Heart Failure - Clinical
  • Speaker : G Bajraktari (Prishtina,XK)

Prognostic value of cognitive tests in chronic heart failure with reduced left ventricular ejection fraction

Congress : Heart Failure 2019

  • Session : Chronic Heart Failure - Clinical
  • Speaker : A Solonovych (Kyiv,UA)

Diabetes is associated with unique pathological mechanisms in heart failure.

Congress : Heart Failure 2019

  • Session : Chronic Heart Failure - Clinical
  • Speaker : J Tromp (Groningen,NL)

Safety and effectiveness of phrenic nerve stimulation in male and female patients with central sleep apnoea

Congress : Heart Failure 2019

  • Session : Chronic Heart Failure - Clinical
  • Speaker : H Fox (Bad Oeynhausen,DE)

Understanding the contemporary use of thiazolidinediones. An analysis of the Diabetes Collaborative Registry

Congress : Heart Failure 2019

  • Session : Chronic Heart Failure - Clinical
  • Speaker : S Arnold (Kansas,US)

Left ventricular dysfunction in HIV infected anti-retroviral therapy naive patients

Congress : Heart Failure 2019

  • Session : Chronic Heart Failure - Clinical
  • Speaker : C Mystakelis (Bethesda Md,US)

Evaluation of lung ultrasound for differential diagnosis of pneumonia and heart failure decompensation

Congress : Heart Failure 2019

  • Session : Chronic Heart Failure - Clinical
  • Speaker : OT Zorya (Moscow,RU)

Vitamin D deficiency and treatment: impact in major outcomes and functional capacity in heart failure patients

Congress : Heart Failure 2019

  • Session : Chronic Heart Failure - Clinical
  • Speaker : M Cravo (Porto,PT)

Members get more

Join now
  • 1ESC Professional Members – access all resources from ESC Congress and ESC Asia with APSC & AFC
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s congress resources
  • 3Under 40 or in training - with a Combined Membership, access resources from all congresses
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are